Singapore markets open in 6 hours 13 minutes
Straits Times Index
3,292.69 +10.64 (+0.32%) S&P 500
5,070.31 +34.62 (+0.69%) Dow
38,227.37 +411.45 (+1.09%) Nasdaq
15,821.25 +163.43 (+1.04%) Bitcoin USD
58,658.43 -1,512.76 (-2.51%) CMC Crypto 200
1,211.50 -127.57 (-9.53%)
Lyell Immunopharma, Inc. (LYEL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:46PM EDT. Market open.
| Previous close | 2.1700 |
| Open | 2.1800 |
| Bid | 2.3200 x 200 |
| Ask | 2.3300 x 100 |
| Day's range | 2.1500 - 2.3350 |
| 52-week range | 1.3200 - 3.9700 |
| Volume | |
| Avg. volume | 898,583 |
| Market cap | 592.729M |
| Beta (5Y monthly) | -0.56 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) market cap decline of US$89m may not have as much of an impact on institutional owners after a year of 1.4% returns
Key Insights Institutions' substantial holdings in Lyell Immunopharma implies that they have significant influence over...
- Zacks
Lyell Immunopharma (LYEL) Is Up 28.45% in One Week: What You Should Know
Does Lyell Immunopharma (LYEL) have what it takes to be a top stock pick for momentum investors? Let's find out.
- GuruFocus.com
Lyell Immunopharma Inc (LYEL) Reports 2023 Financial Results and Business Highlights
LYEL Advances Solid Tumor Cell Therapy Pipeline with Strong Cash Position into 2027
© 2024 Yahoo. All rights reserved.